New York, New York–(Newsfile Corp. – February 15, 2022) – Plantable Health Inc. (NEO: PLBL) (“Plantable” or the “Company“), today announces that is has entered into an investor relations service agreement (the “IR Agreement“) with Apollo Shareholder Relations (“Apollo“), a full-service investor communications agency with a specific focus on the modern investor.
Plantable and Apollo Shareholder Relations
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8118/113785_6aca8668f4e38b78_001full.jpg
“After seeing Apollo’s unique and innovative investor relations offerings, we knew they were a perfect fit for Plantable,” said CEO Dr. Nadja Pinnavaia. “We understand that the investing scene has changed greatly these days, which is why it was important for us to adapt quickly to these changes. We can trust we are in good hands with Apollo to get our Company’s story out there and build relationships with our investors. We value all our investors, big or small, and believe that each and every one of them are critical to our growth.”
Apollo will be providing a number of services to Plantable pursuant to the IR Agreement, which includes but is not limited to strategic communications, news flow planning and press release writing, and attending to investor inquiries through email, phone calls and chatrooms. Apollo’s team is built by experts in capital markets advisory, branding, and infrastructure support. Co-Founder and CEO of Apollo, Kevan Matheson, is a current Capital Markets Partner at Plantable. The IR Agreement is in accordance with the policies of the Neo Exchange and applicable securities laws.
About Apollo Shareholder Relations
Apollo is a full-service investor communications agency with a specific focus on the modern investor. From traditional phone line management to Reddit and everywhere in between, Apollo prides itself on being digitally fluent and community-minded, with an understanding that the communications landscape has dramatically changed in the age of social media and online forums. With expertise in capital markets advisory, branding, and infrastructure support, Apollo is committed to telling your story in a way that resonates with the people you want to reach. To learn more, please visit https://apollorelations.com.
About Plantable® Health Inc.
Plantable is a clinically supported lifestyle change program that combines behavioral psychology, neuroscience and nutritional science to transform health and wellness. Plantable drives healthy weight loss and an improvement in performance, health and well-being by bringing together plant-based meals, personalized coaching support and lifestyle tools to empower people to change their dietary habits. To view the Company’s products and become a customer, please visit plantable.com or click the link here: https://plantable.com/
If you are interested in investing in the Company and would like more information, click the link here: http://invest-plantable.com
Become a part of the Plantable investor community on WhatsApp by joining the link here: https://chat.whatsapp.com/CNupoG2sVitJRhzpfGJGHt
On behalf of the Board of Directors,
Dr. Nadja Pinnavaia
Chief Executive Officer
For investor inquiries please contact:
Olenka Slawski
Corporate Communications and Investor Relations
Email: Invest@plantable.com
Phone: 778-200-4926
Cautionary Note Regarding Forward-Looking Information
Certain statements contained in this news release constitute forward-looking statements as defined under applicable securities laws. All statements in this news release, other than statements of historical facts, that address events or developments that management of the Company expect, are forward-looking statements. Specifically, the references in this news release to the benefits the Company expects to gain from the engagement of its new investor relations firm constitute forward-looking statements. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements, see “Notice to Investors – Forward-Looking Information” and “Risk Factors” in the Prospectus. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113785
NetSuite SuiteSuccess Healthcare Edition helps streamline business processes, expand insights, and enhance decision-making while supporting…
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead…
Presenting a New Innovation in the Field of Spinal Rehabilitation at Physiowell DubaiDUBAI, ARAB EMIRATES…
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare…
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had…
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…